Perkins Coie Trust Co raised its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 1.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,751 shares of the healthcare conglomerate’s stock after buying an additional 235 shares during the period. UnitedHealth Group accounts for about 1.7% of Perkins Coie Trust Co’s investment portfolio, making the stock its 9th largest position. Perkins Coie Trust Co’s holdings in UnitedHealth Group were worth $2,625,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of UNH. Gateway Investment Advisers LLC increased its stake in shares of UnitedHealth Group by 8.8% in the second quarter. Gateway Investment Advisers LLC now owns 815,807 shares of the healthcare conglomerate’s stock worth $115,192,000 after buying an additional 66,274 shares during the last quarter. AGF Investments Inc. increased its stake in shares of UnitedHealth Group by 377.8% in the second quarter. AGF Investments Inc. now owns 423,387 shares of the healthcare conglomerate’s stock worth $59,771,000 after buying an additional 334,776 shares during the last quarter. British Airways Pensions Investment Management Ltd increased its stake in shares of UnitedHealth Group by 15.2% in the second quarter. British Airways Pensions Investment Management Ltd now owns 390,988 shares of the healthcare conglomerate’s stock worth $55,426,000 after buying an additional 51,460 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Robeco Institutional Asset Management B.V. now owns 438,040 shares of the healthcare conglomerate’s stock worth $61,853,000 after buying an additional 2,743 shares during the last quarter. Finally, Ngam Advisors L.P. increased its stake in shares of UnitedHealth Group by 7.3% in the second quarter. Ngam Advisors L.P. now owns 396,685 shares of the healthcare conglomerate’s stock worth $56,013,000 after buying an additional 27,074 shares during the last quarter. 84.92% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% on Monday, hitting $152.11. The stock had a trading volume of 5,029,589 shares. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $154.50. The company’s 50 day moving average price is $143.81 and its 200 day moving average price is $139.88. The firm has a market cap of $144.61 billion, a price-to-earnings ratio of 25.31 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The business earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. During the same quarter in the prior year, the business posted $1.77 EPS. UnitedHealth Group’s revenue for the quarter was up 11.6% compared to the same quarter last year. Analysts expect that UnitedHealth Group Inc. will post $8.01 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be paid a $0.625 dividend. The ex-dividend date is Wednesday, November 30th. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s payout ratio is presently 36.93%.

COPYRIGHT VIOLATION NOTICE: “Perkins Coie Trust Co Boosts Position in UnitedHealth Group Inc. (UNH)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The original version of this news story can be read at https://www.thecerbatgem.com/2016/11/28/perkins-coie-trust-co-boosts-position-in-unitedhealth-group-inc-unh.html.

A number of analysts have issued reports on the company. Jefferies Group reissued a “buy” rating and issued a $163.00 target price on shares of UnitedHealth Group in a research report on Sunday, October 16th. Mizuho raised their target price on UnitedHealth Group from $160.00 to $169.00 and gave the stock a “buy” rating in a research report on Wednesday, October 19th. Evercore ISI assumed coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They issued a “buy” rating and a $155.00 target price for the company. Vetr raised UnitedHealth Group from a “buy” rating to a “buy” rating in a research report on Friday, October 7th. Finally, Credit Suisse Group AG reissued an “outperform” rating and issued a $160.00 target price (up from $155.00) on shares of UnitedHealth Group in a research report on Friday, October 21st. Two research analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $158.03.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,365 shares of the stock in a transaction on Friday, October 21st. The stock was sold at an average price of $144.18, for a total value of $2,071,145.70. Following the completion of the sale, the executive vice president now owns 66,635 shares in the company, valued at approximately $9,607,434.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,460 shares of the stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total value of $822,003.00. Following the completion of the sale, the director now owns 60,052 shares of the company’s stock, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. 1.65% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.